Balyasny Asset Management LLC Medpace Holdings, Inc. Transaction History

Balyasny Asset Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $86,676 - $98,871	-233 Reduced 23.09%	776 $319,000
Q1 2024 May 13, 2024	SELL	$284.87 - $413.31 $49,567 - $71,915	-174 Reduced 14.71%	1,009 $407,000
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $4.81 Million - $6.61 Million	-21,139 Reduced 94.7%	1,183 $362,000
Q3 2023 Nov 14, 2023	BUY	$233.98 - $281.67 $5.22 Million - $6.29 Million	22,322 New	22,322 $5.4 Million
Q3 2020 Nov 16, 2020	SELL	$92.95 - $130.61 $1.03 Million - $1.45 Million	-11,067 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$68.08 - $95.68 $753,441 - $1.06 Million	11,067 New	11,067 $1.03 Million
Q2 2019 Aug 14, 2019	SELL	$53.64 - $65.42 $855,182 - $1.04 Million	-15,943 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$49.38 - $70.58 $67,206 - $96,059	1,361 Added 9.33%	15,943 $940,000
Q4 2018 Feb 14, 2019	SELL	$46.97 - $63.98 $52,888 - $72,041	-1,126 Reduced 7.17%	14,582 $772,000
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $679,371 - $1 Million	15,708 New	15,708 $941,000
Q2 2018 Aug 14, 2018	SELL	$34.03 - $45.46 $491,733 - $656,897	-14,450 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$32.03 - $39.05 $462,833 - $564,272	14,450 New	14,450 $504,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.3B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.